Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,449Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M13.0EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)15.9Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.610-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %2.8PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100,000,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with VEU

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VEUFirst Eagle Investment 2016-06-30 Sold Out $40.43 - $45.07
($43.33)
$ 44.964%Sold Out0
VEUFirst Eagle Investment 2015-12-31 Reduce-0.01%$42.41 - $46.01
($44.45)
$ 44.961%Reduce -86.72%9,800
VEUFirst Eagle Investment 2015-06-30 Buy 0.01%$48.19 - $51.7
($50.15)
$ 44.96-10%New holding73,800
VEUKen Fisher 2013-03-31 Buy $45.45 - $47.27
($46.5)
$ 44.96-3%New holding9,230
VEUJoel Greenblatt 2011-06-30 Sold Out -0.35%$47.24 - $52.01
($49.43)
$ 44.96-9%Sold Out0
VEUJoel Greenblatt 2011-03-31 Add0.27%$45.42 - $49.81
($48.47)
$ 44.96-7%Add 353.24%23,677
VEUJoel Greenblatt 2010-12-31 Buy 0.08%$45.1 - $49.17
($47.23)
$ 44.96-5%New holding5,224
VEUWilbur Ross 2009-12-31 Sold Out -1.36%$41.6 - $45.36
($43.97)
$ 44.962%Sold Out0
VEUWilbur Ross 2009-09-30 Buy 1.36%$34.43 - $43.85
($39.8)
$ 44.9613%New holding190,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VEU is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


VEU: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Snow, Jeffery AlexanderSenior Officer 2016-12-08Buy90,000$5.12778.13view
DINWOODIE, TYLER WAYNE PAULSenior Officer 2016-12-08Buy10,000$0.1334484.62view
Grant, Cheryl AnnDirector, Senior Officer 2016-12-08Buy19,000$0.0674833.33view
Fowler, Christopher HectorSenior Officer 2016-12-08Buy429$32.140.06view
Fowler, Christopher HectorSenior Officer 2016-12-08Buy14$32.1140.02view
Big Sky Uranium Inc.Director, Senior Officer 2016-12-08Buy2,500$1.123914.29view
Roy, Claude10% Security Holder, Director, Senior Officer 2016-12-08Buy400$18.95137.26view
Roy, Claude10% Security Holder, Director, Senior Officer 2016-12-08Buy600$18.97137.01view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-12-08Buy15,000$0.1334484.62view
Skoda, Edward FranklinDirector 2016-12-08Buy25,000$0.2319447.83view

Quarterly/Annual Reports about VEU:

    News about VEU:

    Articles On GuruFocus.com
    What A Wonderful Market (And Where This Leads Us) Jul 07 2014 

    More From Other Websites
    Japan’s Manufacturing PMI Rose: Does the Future Look Brighter? Dec 06 2016
    Why Did Canada’s Manufacturing PMI Improve in November? Dec 06 2016
    Institutional Holdings in Refining Stocks: Who’s a Cut Above? Dec 05 2016
    Is Valeant Exposed to Default Risk? Dec 02 2016
    Yes, There Will Be Margin Erosion for Valeant in 2017 Dec 02 2016
    How Does Valeant Plan to Resume Growth beyond 2016? Dec 01 2016
    Why Wasn’t Valeant’s Enormous Growth Sustainable? Dec 01 2016
    All-Time Highs? Many Investors Likely Had Meager Returns This Month Nov 30 2016
    What Does Valeant’s Institutional Ownership Look Like? Nov 30 2016
    Trump’s Presidency Could Boost Economic Growth Nov 30 2016
    Bull Market: Expected for Gold but Not for Bonds Nov 30 2016
    Where Do Institutional Holdings in Phillips 66 Stand? Nov 29 2016
    What the Majority of Analysts Are Recommending for Phillips 66 Now Nov 24 2016
    Biosimilar Business May Be a Strong Growth Opportunity for Teva Nov 23 2016
    Integrated Energy Firms’ Leverage in 3Q16 Nov 23 2016
    Copaxone May Face Competitive Pressures in the Future Nov 21 2016
    Neurology, Generics Businesses Drag Valeant’s 2017 Revenue and EBITDA Nov 15 2016
    How Did VRX’s US Diversified Business Perform in 3Q16? Nov 14 2016
    Analyst Recommendations for Petrobras: A Mixed Bag Nov 14 2016
    Gauging Valeant Pharmaceuticals’s 3Q16 Segmental Performance Nov 11 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)